This new report from RAND Corporation provides a nonpartisan primer that should be of interest to those who are new to the field of drug policy, as well as those who have been working in the trenches. It begins with an overview of problems and policies related to illegal drugs in the United States, including the nonmedical use of prescription drugs. It then discusses the efficacy of U.S. drug policies and programs, including long-standing issues that deserve additional attention. Next, the paper lists the major funders of research and analysis in the area and describes their priorities. By highlighting the issues that receive most of the funding, this discussion identifies where gaps remain.
The press release can be accessed at: http://www.rand.org/news/press/2012/09/18.html
The report can be accessed at: http://www.rand.org/pubs/occasional_papers/OP393.html
Source: RAND Corporation – September 18, 2012